Cargando…
Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model
Despite evidence that deregulated Notch signalling is a master regulator of multiple myeloma (MM) pathogenesis, its contribution to myeloma bone disease remains to be resolved. Notch promotes survival of human MM cells and triggers human osteoclast activity in vitro. Here, we show that inhibition of...
Autores principales: | Schwarzer, R, Nickel, N, Godau, J, Willie, B M, Duda, G N, Cirovic, B, Leutz, A, Manz, R, Bogen, B, Dörken, B, Jundt, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080208/ https://www.ncbi.nlm.nih.gov/pubmed/24927406 http://dx.doi.org/10.1038/bcj.2014.37 |
Ejemplares similares
-
A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease
por: Hofgaard, Peter O., et al.
Publicado: (2012) -
Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches
por: Wong, David, et al.
Publicado: (2014) -
Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315
Publicado: (1978) -
Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC- 315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells
Publicado: (1982) -
Overexpression of VEGF in the MOPC 315 Plasmacytoma Induces Tumor Immunity in Mice
por: Kim, Byung-Gyu, et al.
Publicado: (2022)